JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB18443

Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control

Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control

Be the first to review this product! Submit a review

|

(83 Publications)

Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (ab18443) is a mouse monoclonal antibody used in Western Blot, Flow Cytometry, IP, IHC-P, IHC-Fr.

- Over 50 publications
- Trusted since 2005

查看别名

Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4

11 Images
ChIP - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)
  • ChIP

Lab

ChIP - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)

Chromatin was prepared from HeLa cells according to the Abcam Dual-X-ChIP protocol. Cells were fixed with formaldehyde for 10min.
The ChIP was performed with 25 µg of chromatin, 5 µg of ab5408 (red), or 5 µg of Mouse IgG1 ab18443 (gray) and 25 µl of Protein A/G Dynabeads. The immunoprecipitated DNA was quantified by real time PCR (Sybr green approach).
Primers and probes are located in the first kb of the transcribed region.

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)
  • IP

Lab

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)

Hsp27 was immunoprecipitated from HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate 10 μg with ab2790 1/1000 dilution (0.45 μg/ml). Western blot was performed on the immunoprecipitate using ab2790 at 1/1000 dilution. Capture antibody, 1/30 dilution (2μg in 0.35mg lysates).

Mouse monoclonal IgG1, kappa (ab18443) Isotype Control was used instead of ab2790 in HeLa whole cell lysate (Lane 3).

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Secondary antibody (ab131368), mouse IgG for IP (HRP) used at 1/1000 dilution.

All lanes:

Immunoprecipitation - Anti-Hsp27 antibody [G3.1] (<a href='/products/primary-antibodies/hsp27-antibody-g31-ab2790'>ab2790</a>) at 1/1000 dilution

All lanes:

HeLa (human cervix adenocarcinoma epithelial cell ) whole cell lysate at 10 µg

Secondary

All lanes:

Immunoprecipitation - Anti-mouse IgG for IP (HRP) (<a href='/products/secondary-antibodies/mouse-igg-for-ip-hrp-ab131368'>ab131368</a>) at 1/1000 dilution

Observed band size: 27 kDa

false

Exposure time: 7s

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)
  • IP

Supplier Data

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)

CP2c was immunoprecipitated from 0.35 mg K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate 10 ug with ab308611 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab308611 at 1/1000 dilution. mouse IgG for IP (HRP) (ab131368) was used at 1/1000 dilution. Lane 1 : K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate Lane 2 : ab308611 IP in K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate Lane 3 : Mouse monoclonal IgG (ab18443) instead of ab308611 in K-562 whole cell lysate Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 24 seconds

All lanes:

Immunoprecipitation - Anti-CP2c antibody [14/LSF] (<a href='/products/primary-antibodies/cp2c-antibody-14-lsf-ab308611'>ab308611</a>) at 1/30 dilution

All lanes:

K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate

Secondary

All lanes:

Immunoprecipitation - Anti-mouse IgG for IP (HRP) (<a href='/products/secondary-antibodies/mouse-igg-for-ip-hrp-ab131368'>ab131368</a>) at 1/1000 dilution

false

Exposure time: 24s

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)
  • IP

Supplier Data

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)

p53 was immunoprecipitated from 0.35 mg HEK-293 (human embryonic kidney epithelial cell) whole cell lysate with ab308609 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab308609 at 1/1000 dilution. mouse IgG for IP (HRP) (ab131368) was used at 1/5000 dilution. Lane 1 : HEK-293 whole cell lysate Lane 2 : ab308609 IP in HEK-293 whole cell lysate Lane 3 : Mouse IgG1 monoclonal isotype control (ab18443) instead of ab308609 in HEK-293 whole cell lysate Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 23 seconds. The binding pattern observed is consistent with what has been described in the literature (PMID : 31045216; PMID : 16131611).

All lanes:

Immunoprecipitation - Anti-p53 antibody [G59-12] (<a href='/products/primary-antibodies/p53-antibody-g59-12-ab308609'>ab308609</a>) at 1/1000 dilution

All lanes:

HEK-293 whole cell lysate at 10 µg

Secondary

All lanes:

Immunoprecipitation - Anti-mouse IgG for IP (HRP) (<a href='/products/secondary-antibodies/mouse-igg-for-ip-hrp-ab131368'>ab131368</a>) at 1/5000 dilution

false

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)
  • IP

Lab

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)

Histone H2B was immunoprecipitated from 0.35 mg HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate with ab52484 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab52484 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.  Lane 1 : HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate  10 ug Lane 2 : ab52484 IP in HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate Lane 3 : Mouse monoclonal IgG (ab18443) instead of ab52484 in HeLa whole cell lysate Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 32 seconds.

All lanes:

Immunoprecipitation - Anti-Histone H2B antibody [mAbcam 52484] - ChIP Grade (<a href='/products/primary-antibodies/histone-h2b-antibody-mabcam-52484-chip-grade-ab52484'>ab52484</a>) at 1/30 dilution

All lanes:

HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate

Secondary

All lanes:

Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution

Predicted band size: 14 kDa

Observed band size: 15 kDa

false

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)
  • IP

Supplier Data

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)

CP2c was immunoprecipitated from 0.35 mg Hepa1-6 (mouse hepatoma epithelial cell) whole cell lysate 10 ug with ab308611 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab308611 at 1/1000 dilution. Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) was used at 1/10000 dilution. Lane 1 : Hepa1-6 (mouse hepatoma epithelial cell) whole cell lysate Lane 2 : ab308611 IP in Hepa1-6 (mouse hepatoma epithelial cell) whole cell lysate Lane 3 : Mouse monoclonal IgG (ab18443) instead of ab308611 in Hepa1-6 whole cell lysate Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 59 seconds

All lanes:

Immunoprecipitation - Anti-CP2c antibody [14/LSF] (<a href='/products/primary-antibodies/cp2c-antibody-14-lsf-ab308611'>ab308611</a>) at 1/30 dilution

All lanes:

Hepa1-6 (mouse hepatoma epithelial cell) whole cell lysate

Secondary

All lanes:

Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1/10000 dilution

false

Exposure time: 59s

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)
  • IP

Supplier Data

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)

CP2c was immunoprecipitated from 0.35 mg C6 (rat glial tumor glial cell) whole cell lysate 10 ug with ab308611 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab308611 at 1/1000 dilution. Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) was used at 1/10000 dilution. Lane 1 : C6 (rat glial tumor glial cell) whole cell lysate Lane 2 : ab308611 IP in C6 (rat glial tumor glial cell) whole cell lysate Lane 3 : Mouse monoclonal IgG (ab18443) instead of ab308611 in C6 whole cell lysate Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 59 seconds

All lanes:

Immunoprecipitation - Anti-CP2c antibody [14/LSF] (<a href='/products/primary-antibodies/cp2c-antibody-14-lsf-ab308611'>ab308611</a>) at 1/30 dilution

All lanes:

C6 (rat glial tumor glial cell) whole cell lysate

Secondary

All lanes:

Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1/10000 dilution

false

Exposure time: 59s

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)
  • IP

Supplier Data

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)

SH3GL1/Endophilin A2 was immunoprecipitated from 0.35 mg Rat testis tissue lysate with ab317835 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab317835 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.

Lane 1 : Rat testis tissue lysate
Lane 2 : ab317835 IP in Rat testis tissue lysate
Lane 3 : Mouse monoclonal IgG (ab18443) instead of ab317835 in rat testis tissue lysate

All lanes:

Immunoprecipitation - Anti-SH3GL1/Endophilin A2 antibody [K51/1] (<a href='/products/primary-antibodies/sh3gl1-endophilin-a2-antibody-k51-1-ab317835'>ab317835</a>) at 1/30 dilution

All lanes:

Rat testis tissue lysate

Secondary

All lanes:

Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution

false

Exposure time: 41s

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)
  • IP

Supplier Data

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)

SHP2 was immunoprecipitated from 0.35 mg NIH/3T3 (mouse embryonic fibroblast) whole cell lysate 10 µg with ab290646 at 1/30 dilution (2µg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab290646 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution. Lane 1 : NIH/3T3 (mouse embryonic fibroblast) whole cell lysate 10 µg Lane 2 : ab290646 IP in NIH/3T3 whole cell lysate Lane 3 : Mouse IgG1 monoclonal (ab18443) instead of ab290646 in NIH/3T3 whole cell lysate Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 3 seconds

Lane 1:

Immunoprecipitation - Anti-SHP2 antibody [79/PTP1D/SHP2] (<a href='/products/primary-antibodies/shp2-antibody-79-ptp1d-shp2-ab290646'>ab290646</a>) at 1/30 dilution

Lane 2:

Immunoprecipitation - Anti-SHP2 antibody [79/PTP1D/SHP2] (<a href='/products/primary-antibodies/shp2-antibody-79-ptp1d-shp2-ab290646'>ab290646</a>) at 1/1000 dilution

All lanes:

NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 10 µg

Predicted band size: 68 kDa

false

Exposure time: 3s

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)
  • IP

Lab

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)

Histone H2B was immunoprecipitated from 0.35 mg NIH/3T3 (mouse embryonic fibroblast), whole cell lysate with ab52484 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab52484 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP) (ab131366) was used at 1/5000 dilution.  Lane 1 : NIH/3T3 (mouse embryonic fibroblast), whole cell lysate 10 μg Lane 2 : ab52484 IP in NIH/3T3 (mouse embryonic fibroblast), whole cell lysate 10 μg Lane 3 : Mouse monoclonal IgG (ab18443) instead of ab52484 in NIH/3T3 whole cell lysate Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 32 seconds.

All lanes:

Immunoprecipitation - Anti-Histone H2B antibody [mAbcam 52484] - ChIP Grade (<a href='/products/primary-antibodies/histone-h2b-antibody-mabcam-52484-chip-grade-ab52484'>ab52484</a>) at 1/30 dilution

All lanes:

NIH/3T3 (mouse embryonic fibroblast), whole cell lysate

Secondary

All lanes:

Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution

false

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)
  • IP

Supplier Data

Immunoprecipitation - Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (AB18443)

Influenza A virus PB1 protein was immunoprecipitated from 0.35 mg 293T cells transfected with a influenza A virus (H3N2) PB1 expression vector containing a myc-his-tag whole cell lysate with ab324448 at 1/50 dilution (2 ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab324448 at 1/1000 dilution.

Blocking and dilution buffer and concentration : 5% NFDM/TBST

All lanes:

Immunoprecipitation - Anti-Influenza A virus PB1 protein antibody [F5-19] (<a href='/products/primary-antibodies/influenza-a-virus-pb1-protein-antibody-f5-19-ab324448'>ab324448</a>) at 1/1000 dilution

Lane 1:

(Input) 293T cells transfected with a influenza A virus (H3N2) PB1 expression vector containing a myc-his-tag whole cell lysate at 10 µg

Lane 2:

<a href='/products/primary-antibodies/influenza-a-virus-pb1-protein-antibody-f5-19-ab324448'>ab324448</a> at 1/50 IP in 293T cells transfected with a influenza A virus (H3N2) PB1 expression vector containing a myc-his-tag whole cell lysate at 10 µg

Lane 3:

Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (ab18443) instead of <a href='/products/primary-antibodies/influenza-a-virus-pb1-protein-antibody-f5-19-ab324448'>ab324448</a> in 293T cells transfected with a influenza A virus (H3N2) PB1 expression vector containing a myc-his-tag whole cell lysate at 10 µg

Secondary

All lanes:

Immunoprecipitation - Anti-mouse IgG for IP (HRP) (<a href='/products/secondary-antibodies/mouse-igg-for-ip-hrp-ab131368'>ab131368</a>) at 1/5000 dilution

Observed band size: 85 kDa

false

Exposure time: 8s

不同偶联物与剂型 (8)

  • 660 APC

    APC Mouse IgG1 kappa [MOPC-21] - Isotype Control

  • 785 APC/Cy7®

    APC/Cy7® Mouse IgG1 kappa [MOPC-21] - Isotype Control

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Mouse IgG1 [MOPC-21] - Isotype Control

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Mouse IgG1 kappa [MOPC-21] - Isotype Control

  • Biotin

    Biotin Mouse IgG1, Kappa Monoclonal [MOPC-21] - isotype control

  • 519 FITC

    FITC Mouse IgG1 kappa [MOPC-21] - Isotype Control

  • 778 PE/Cy7®

    PE/Cy7® Mouse IgG1 kappa Isotype Control

  • 695 PerCP/Cy5.5®

    PerCP/Cy5.5® Mouse IgG1, Kappa Monoclonal [MOPC-21] - Isotype Control

关键信息

宿主种属

Mouse

克隆

Monoclonal

克隆号

MOPC-21

亚型

IgG1

轻链类型

kappa

不含载体蛋白

No

应用

Flow Cyt, IHC-Fr, IHC-P, IP, WB

applications

特异性

MOPC-21 immunoglobulin has unknown specificity and was chosen as an isotype control after screening on a variety of resting, activated, live and fixed rat and human tissues.

产品详情

What is this antibody validated in?
Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (ab18443) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr). Trusted by the scientific community
Anti- Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control (ab18443) was first used in a scientific publication in 2005 and has been cited over 50 times in peer-reviewed journals.

Other related products
We have a range of other formats of antibody clone [MOPC-21] also available for your convenience: ab18443, FITC - ab106163, ab157226, Alexa Fluor® 488 - ab234075, Alexa Fluor® 647 - ab239459, APC - ab239462, ab239463, ab239464, ab242443, ab288147, ab288148

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein G
存储溶液
pH: 7.2 Preservative: 0.09% Sodium azide Constituents: PBS
运输条件
Blue Ice
推荐的短期储存条件
+4°C
推荐的长期储存条件
+4°C

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region interacts (via the fragment crystallizable, Fc) with the Fc receptors on innate immune cells to mediate humoral effector functions. Ig gamma-4 (IgG4) isotype does not elicit antibody-dependent cellular cytotoxicity (ADDC) or complement-dependent cytotoxicity (CDC). Instead it is likely involved in immune tolerance mechanisms to allergens and parasites either by blocking IgE-antigen complex formation or by directly inhibiting mast cell degranulation through Fc receptor signaling. In the context of tumorigenesis, it may participate in immunosuppressive mechanisms.
See full target information IGHG4

文献 (83)

Recent publications for all applications. Explore the full list and refine your search

PloS one 20:e0323810 PubMed40367052

2025

Suppression of mechanical hypersensitivity and change in the expression of the dopamine D2 receptor by administration of anti-CGRP antibody into the trigeminal ganglion in trigeminal neuropathic pain model rats.

Applications

Unspecified application

Species

Unspecified reactive species

Hiroharu Maegawa,Nayuka Usami,Chiho Kudo,Hitoshi Niwa

Molecular medicine reports 31: PubMed40084693

2025

Exosomes derived from baicalin‑pretreated mesenchymal stem cells mitigate atherosclerosis by regulating the SIRT1/NF‑κB signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaochun Yang,Wei Wu,Weitian Huang,Junfeng Fang,Yunli Chen,Xiaoyan Chen,Xiaolan Lin,Yanbin He

iScience 28:111758 PubMed39906564

2025

Multilevel plasticity and altered glycosylation drive aggressiveness in hypoxic and glucose-deprived bladder cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Andreia Peixoto,Dylan Ferreira,Andreia Miranda,Marta Relvas-Santos,Rui Freitas,Tim S Veth,Andreia Brandão,Eduardo Ferreira,Paula Paulo,Marta Cardoso,Cristiana Gaiteiro,Sofia Cotton,Janine Soares,Luís Lima,Filipe Teixeira,Rita Ferreira,Carlos Palmeira,Albert J R Heck,Maria José Oliveira,André M N Silva,Lúcio Lara Santos,José Alexandre Ferreira

Molecular medicine reports 31: PubMed39540350

2024

Silencing PPAP2C inhibits lung adenocarcinoma migration and invasion via the ERK/JNK pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yi Li,Wenhui Dang,Ting Jiao,Mengying Zhang,Wei Li

The EMBO journal 43:5972-6000 PubMed39448884

2024

Cyclophilin D plays a critical role in the survival of senescent cells.

Applications

Unspecified application

Species

Unspecified reactive species

Margherita Protasoni,Vanessa López-Polo,Camille Stephan-Otto Attolini,Julian Brandariz,Nicolas Herranz,Joaquin Mateo,Sergio Ruiz,Oscar Fernandez-Capetillo,Marta Kovatcheva,Manuel Serrano

Cell reports. Medicine 5:101716 PubMed39241773

2024

Five miRNAs identified in fucosylated extracellular vesicles as non-invasive diagnostic signatures for hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Boan Li,Kun Hao,Mengyang Li,Ailan Wang,Huixue Tang,Lida Xu,Cuidie Ma,Wenqian Du,Lijuan Sun,Xufeng Hou,Tianye Jia,Aixia Liu,Qi Gao,Zhiming Zhao,Ronghua Jin,Ruifu Yang

Frontiers in immunology 15:1367432 PubMed38994364

2024

The mammosphere-derived epithelial cell secretome modulates neutrophil functions in the bovine model.

Applications

Unspecified application

Species

Unspecified reactive species

Rebecca M Harman,Anja Sipka,Kelly A Oxford,Leane Oliveira,Lucas Huntimer,Daryl V Nydam,Gerlinde R Van de Walle

Genes to cells : devoted to molecular & cellular mechanisms 29:746-756 PubMed38964745

2024

An N-terminal and ankyrin repeat domain interactome of Shank3 identifies the protein complex with the splicing regulator Nono in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Sayaka Okuzono,Fumihiko Fujii,Daiki Setoyama,Ryoji Taira,Yohei Shinmyo,Hiroki Kato,Keiji Masuda,Kousuke Yonemoto,Satoshi Akamine,Yuki Matsushita,Yoshitomo Motomura,Takeshi Sakurai,Hiroshi Kawasaki,Kihoon Han,Takahiro A Kato,Hiroyuki Torisu,Dongchon Kang,Yusaku Nakabeppu,Shouichi Ohga,Yasunari Sakai

Vaccines 12: PubMed38793810

2024

The Biodistribution of the Spike Protein after Ad26.COV2.S Vaccination Is Unlikely to Play a Role in Vaccine-Induced Immune Thrombotic Thrombocytopenia.

Applications

Unspecified application

Species

Unspecified reactive species

Sonia Marquez-Martinez,Selina Khan,Joan van der Lubbe,Laura Solforosi,Lea M M Costes,Ying Choi,Satish Boedhoe,Mieke Verslegers,Marjolein van Heerden,Wendy Roosen,Sandra De Jonghe,Hendy Kristyanto,Veronica Rezelj,Jenny Hendriks,Jan Serroyen,Jeroen Tolboom,Frank Wegmann,Roland C Zahn

Nature cancer 5:448-462 PubMed38267628

2024

The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2.

Applications

Unspecified application

Species

Unspecified reactive species

Selim Chaib,José Alberto López-Domínguez,Marta Lalinde-Gutiérrez,Neus Prats,Ines Marin,Olga Boix,Andrea García-Garijo,Kathleen Meyer,María Isabel Muñoz,Mònica Aguilera,Lidia Mateo,Camille Stephan-Otto Attolini,Susana Llanos,Sandra Pérez-Ramos,Marta Escorihuela,Fatima Al-Shahrour,Timothy P Cash,Tamara Tchkonia,James L Kirkland,María Abad,Alena Gros,Joaquín Arribas,Manuel Serrano
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com